Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer

Objectives. The aim of our study was to examine serum anti-Müllerian hormone (AMH) concentration in ovarian cancer patients in relation to clinicopathological features, such as a pathological subtype of the tumor, (FIGO) stage, grading, and overall 5-year survival. Material and Methods. We enrolled...

Full description

Bibliographic Details
Main Authors: Pawel Walentowicz, Pawel Sadlecki, Magdalena Krintus, Grazyna Sypniewska, Aneta Mankowska-Cyl, Marek Grabiec, Malgorzata Walentowicz-Sadlecka
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2013/517239